Position in ABBV
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$4,650,810
+$614,197 QoQ
Shares Held
18,482
-0.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.35%
of 13F equity value
Holder Rank
#1,357
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 70%
Shared 29%
None 1%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PEOPLES FINANCIAL SERVICES CORP. holds $30,501,464 across 11 Drug Manufacturers - General names. ABBV ranks #3 (15.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,244 | $13,486,391 | |
| 2 | JNJ |
Johnson & Johnson
|
19,251 | $4,889,175 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
18,482 | $4,650,810 | |
| 4 | MRK |
Merck & Co., Inc.
|
22,170 | $2,848,845 | |
| 5 | AMGN |
Amgen Inc
|
4,453 | $1,612,520 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
26,066 | $1,501,922 | |
| 7 | PFE |
Pfizer Inc
|
36,641 | $882,314 | |
| 8 | NVS |
Novartis AG
|
1,703 | $266,893 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,650,810 | 18,482 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $4,036,613 | 18,560 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $4,291,270 | 18,781 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $4,577,082 | 19,768 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $3,693,651 | 19,899 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $4,562,297 | 21,775 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $3,928,946 | 22,110 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $4,398,668 | 22,274 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $4,246,492 | 24,758 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $4,629,891 | 25,425 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $4,103,760 | 26,481 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $3,964,547 | 26,597 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $3,568,592 | 26,487 | Shares | Sole | 2023-07-11 | |
| 2023-03-31 | $4,287,689 | 26,904 | Shares | Sole | 2023-04-13 | |
| 2022-12-31 | $4,451,708 | 27,546 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $3,738,150 | 27,853 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $4,287,867 | 27,996 | Shares | Sole | 2022-07-07 | |
| 2022-03-31 | $4,566,638 | 28,170 | Shares | Sole | 2022-04-15 | |
| 2021-12-31 | $4,128,616 | 30,492 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $3,193,059 | 29,601 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $3,389,111 | 30,088 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $3,265,321 | 30,173 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $3,211,178 | 29,969 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $2,531,088 | 28,897 | Shares | Sole | 2020-10-07 | |
| 2020-06-30 | $2,753,654 | 28,047 | Shares | Sole | 2020-07-10 | |
| 2020-03-31 | $1,905,740 | 25,013 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||